We are live on ! Find out more
HALO icon

Halozyme

324 hedge funds and large institutions have $5.29B invested in Halozyme in 2021 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 137 increasing their positions, 98 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more call options, than puts

Call options by funds: $22M | Put options by funds: $8.56M

54% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 28

40% more repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 98

4% more funds holding

Funds holding: 313324 (+11)

0.27% more ownership

Funds ownership: 91.11%91.38% (+0.27%)

10% less capital invested

Capital invested by funds: $5.87B → $5.29B (-$582M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
324
Holders Change
+11
Holders Change %
+3.51%
% of All Funds
5.67%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
43
Increased
137
Reduced
98
Closed
28
Calls
$22M
Puts
$8.56M
Net Calls
+$13.4M
Net Calls Change
+$8.64M
Name Holding Trade Value Shares
Change
Change in
Stake
ASN
351
Advisory Services Network
Georgia
-$1K -16 Closed
PWMG
352
Prestige Wealth Management Group
New Jersey
+$502 +12 New

HALO Hedge Fund Activity: Q3 2021 in Review

324 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2021, worth a combined $5.29B — down 9.9% from $5.87B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new HALO positions and 28 closed out — a net gain of 15 holders — while 137 added to existing stakes and 98 trimmed.

The largest buyer was Swedbank, adding an estimated $21.7M. The largest seller was Bellevue Group, cutting an estimated $54.5M.

  • 324 institutional investors held Halozyme (HALO) as of Q3 2021, up from 313 in Q2 2021.
  • Funds reported $5.29B of Halozyme stock for Q3 2021, down 9.9% quarter-over-quarter.
  • 43 funds opened new Halozyme positions in Q3 2021 and 28 closed out, a net change of +15 holders.
  • The largest Halozyme buyer in Q3 2021 was Swedbank, an estimated $21.7M added.
  • The largest Halozyme seller in Q3 2021 was Bellevue Group, an estimated $54.5M sold.

Based on aggregated 13F filings for Q3 2021.